Four years of clinical investigations with nifuratel.
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D005260:Female; D005664:Furazolidone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009581:Nitrofurans / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000188:drug therapy*; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D009581:Nitrofurans; D010080:Oxazoles; D005664:Furazolidone; D009582:Nitrofurantoin